A story in the Nov. 22, 2000, issue of BioWorld Today on ArQule Inc. should have indicated the company increased the shares offered from the amount initially expected - 2.5 million shares - by 420,000 shares to 2.92 million shares. ArQule's total public offering of 2.92 million shares, not including shares offered underwriters to cover overallotments, priced at $22.50, grossed the company $65.7 million.

Editor's Note: The error was corrected Monday in BioWorld Online.